title: Outcome of fetal exomphalos diagnosed at 11-14 weeks of gestation.
abstract: OBJECTIVE
  To determine whether sonographic findings in cases of exomphalos detected at the 11-14-week scan can be used to guide pregnancy management.
  
  
  METHODS
  Retrospective study of cases of exomphalos identified from the Fetal Medicine Unit database, University College London Hospitals between January 1998 and January 2010. Pregnancy and neonatal data were ascertained from maternal and neonatal records. Fetal exomphalos was categorized into three groups: exomphalos associated with other major structural malformation(s), isolated exomphalos with increased nuchal translucency (NT) and isolated exomphalos with normal NT.
  
  
  RESULTS
  A total of 98 cases of exomphalos were identified, of which 45 (45.9%) were associated with other major structural malformation(s), identified antenatally. Isolated exomphalos was found with increased NT in 22 cases (22.4%) and with normal NT in 31 cases (31.6%). Of 80 (81.6%) fetuses that were karyotyped, 43 (53.8%) had a chromosomal abnormality; the most common aneuploidy was trisomy 18 (n = 31; 72.1%). Where exomphalos was associated with other major structural abnormalities, or was isolated with increased NT, the incidence of aneuploidy was high, at 78.9% and 72.2%, respectively. Cases of isolated exomphalos with normal NT were all euploid. In 21 cases (21.4%), exomphalos resolved later in pregnancy and none had apparent abnormalities at birth; isolated exomphalos persisted in only three neonates (3.1%).
  
  
  CONCLUSIONS
  The finding of a major structural abnormality or of increased NT in association with exomphalos in the first trimester implies a high risk of aneuploidy. Parents can be reassured that fetuses with isolated exomphalos and normal NT are likely to be euploid.
authors.affiliation: Fetal Medicine Unit, Institute for Women's Health, University College London Hospitals NHS Foundation Trust, London, UK. asmakhalil79@googlemail.com
authors.forename: A
authors.initials: A
authors.lastname: Khalil
authors.forename: C
authors.initials: C
authors.lastname: Arnaoutoglou
authors.forename: M
authors.initials: M
authors.lastname: Pacilli
authors.forename: A
authors.initials: A
authors.lastname: Szabo
authors.forename: A L
authors.initials: AL
authors.lastname: David
authors.forename: P
authors.initials: P
authors.lastname: Pandya
mesh_terms: D000293:Adolescent; D000328:Adult; D025063:Chromosome Disorders / Q000097:blood / Q000175:diagnosis* / Q000196:embryology; D005260:Female; D005865:Gestational Age; D006554:Hernia, Umbilical / Q000097:blood / Q000175:diagnosis* / Q000196:embryology; D006801:Humans; D007231:Infant, Newborn; D007621:Karyotyping; D008131:London; D008875:Middle Aged; D048208:Nuchal Translucency Measurement; D011247:Pregnancy; D011256:Pregnancy Outcome; D011261:Pregnancy Trimester, First; D018566:Pregnancy, High-Risk; D011379:Prognosis; D012189:Retrospective Studies; D012307:Risk Factors; D055815:Young Adult